GlaxoSmithKline has won orders for H1N1 swine flu vaccine from a further nine governments, taking the total number of doses ordered to 291 million, the British-based drugmaker said on Tuesday.
With more orders still to come, it could be in line for a flu vaccine windfall of more than $3 billion in the next six months or so, according to industry analysts.
Glaxo has previously said it expects to sell pandemic vaccine for around the same price as seasonal flu shots, which fetch about 5 pounds a dose, implying its total booked orders are now worth around 1.5 billion pounds ($2.54 billion).
on the way now with switch strategy, page-24
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$308.53 |
Change
3.060(1.00%) |
Mkt cap ! $149.0B | |||
| Open | High | Low | Value | Volume |
| $308.99 | $308.99 | $305.97 | $232.7M | 769.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 913 | $307.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $308.59 | 20 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |